Labcorp to join Morgan Stanley healthcare conference
Labcorp Holdings Inc. (LH) announced that members of its executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, at 11:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Labcorp Holdings Inc. (LH) announced that members of its executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, at 11:30 a.m. ET. A live audio webcast will be accessible through Labcorp’s investor relations website and archived for 180 days.
Labcorp describes itself as a global provider of innovative and comprehensive laboratory services, with nearly 71,000 employees serving clients in about 100 countries, supporting more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performing over 750 million tests annually.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Conference date and time: September 15, 2026 at 11:30 a.m. ET
Webcast archive period: 180 days
Employees: nearly 71,000 employees
+3 more
6 metrics
Conference date and time
September 15, 2026 at 11:30 a.m. ET
Timing of Labcorp’s fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference
Webcast archive period
180 days
Length of time the fireside chat webcast will remain available on the investor relations website
Employees
nearly 71,000 employees
Labcorp’s reported global workforce
Countries served
approximately 100 countries
Geographic reach of Labcorp’s clients
FDA approvals supported
more than 85% of new drugs and therapeutic products approved by the FDA in 2025
Share of 2025 FDA approvals Labcorp reports supporting
Tests performed
more than 750 million tests
Annual patient tests performed worldwide
Key Terms
fireside chat, webcast, therapeutic products, Inline XBRL
4 terms
fireside chat financial
"will participate in a fireside chat at the Morgan Stanley 24th Annual"
webcast financial
"A live audio webcast of the fireside chat will be available"
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
therapeutic products medical
"new drugs and therapeutic products approved by the FDA in 2025"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What event is Labcorp (LH) highlighting in this Form 8-K?
Labcorp reported that its executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, at 11:30 a.m. ET, with the session available via live audio webcast.
How can investors access Labcorp’s (LH) conference appearance?
Investors can access a live audio webcast of Labcorp’s fireside chat via the company’s investor relations website at ir.labcorp.com. The webcast will be archived for 180 days following the event.
What scale of operations does Labcorp (LH) report in this disclosure?
Labcorp reports having nearly 71,000 employees, serving clients in approximately 100 countries, supporting more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performing more than 750 million tests for patients worldwide.
What exhibit is included with Labcorp’s (LH) Form 8-K?
The filing includes Exhibit 99.1, a press release dated August 28, 2026, announcing Labcorp’s participation in the Morgan Stanley 24th Annual Global Healthcare Conference, and Exhibit 104, the cover page Inline XBRL data file.
What does Labcorp (LH) describe as its core business in this filing?
Labcorp describes itself as a global leader of innovative and comprehensive laboratory services that supports doctors, hospitals, pharmaceutical companies, researchers and patients by providing diagnostic and drug development laboratory capabilities to improve health and lives.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Date of earliest event reported)
(Exact Name of Registrant as Specified in its Charter)
| (State or other jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| , | ||||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(Registrant’s telephone number including area code) 336 -229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01. | Regulation FD Disclosure. | ||||
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on August 28, 2026 that members of the executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 11:30 a.m. ET.
A live audio webcast of the fireside chat will be available via the Labcorp Investor Relations website at ir.labcorp.com and archived for replay for 180 days following the event.
A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. | |||||||
| Exhibit | Exhibit Name | |||||||
| Exhibit 99.1 | Press Release dated August 28, 2026 issued by Labcorp Holdings Inc. | |||||||
| Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LABCORP HOLDINGS INC.
Registrant
| Date: August 28, 2026 | By: | /s/KATHRYN W. KYLE | ||||||
| Kathryn W. Kyle | ||||||||
| Executive Vice President, Chief Legal Officer and Corporate Secretary | ||||||||
FOR IMMEDIATE RELEASE
| Media | Investors | |||||||
| Racquel White | Dewey Steadman | |||||||
| Media@Labcorp.com | Investor@Labcorp.com | |||||||
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
BURLINGTON, N.C., (Aug. 28, 2026) — Labcorp Holdings, Inc.(NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 15, at 11:30 a.m. ET.
A live audio webcast of the fireside chat will be available via the Labcorp Investor Relations website at ir.Labcorp.com and archived for 180 days following the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.